{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:38:51Z","timestamp":1793835531924,"version":"4.6.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016204","name":"Ministry of Higher Education, Science, Research and Innovation, Thailand","doi-asserted-by":"publisher","award":["F01\\u2010683R\\u201017\\u2010046"],"award-info":[{"award-number":["F01\\u2010683R\\u201017\\u2010046"]}],"id":[{"id":"10.13039\/501100016204","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007288","name":"Mahasarakham University","doi-asserted-by":"publisher","award":["6621005\/2566"],"award-info":[{"award-number":["6621005\/2566"]}],"id":[{"id":"10.13039\/501100007288","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ctim.2025.103295","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:08:11Z","timestamp":1761898091000},"page":"103295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effectiveness and safety of turmeric for the treatment of COVID-19: An updated systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"95","author":[{"given":"Ratree","family":"Sawangjit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranrat","family":"Sadoyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siripong","family":"Manosanthipaibul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattawat","family":"Teerawattanapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panupong","family":"Puttarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulthanit","family":"Wanaratna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawiwan","family":"Charoensup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonsit","family":"Hiransai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thunyaluk","family":"Meetam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4572-8794","authenticated-orcid":false,"given":"Nathorn","family":"Chaiyakunapruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ctim.2025.103295_bib1","doi-asserted-by":"crossref","first-page":"e02404","DOI":"10.1128\/aac.02404-21","article-title":"New perspectives on antimicrobial agents: molnupiravir and nirmatrelvir\/ritonavir for treatment of COVID-19","volume":"66","author":"Atmar","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ctim.2025.103295_bib2","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.ctim.2025.103295_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijsu.2020.02.034","article-title":"World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)","volume":"76","author":"Sohrabi","year":"2020","journal-title":"Int J Surg"},{"issue":"20","key":"10.1016\/j.ctim.2025.103295_bib4","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","article-title":"Mechanisms of long COVID and the path toward therapeutics","volume":"187","author":"Peluso","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ctim.2025.103295_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejim.2022.05.024","article-title":"Efficacy and safety of molnupiravir for COVID-19 patients","volume":"102","author":"Fatima","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ctim.2025.103295_bib6","doi-asserted-by":"crossref","unstructured":"Yazdanpanah F., Hamblin M.R., Rezaei N. The immune system and COVID-19: Friend or foe? Life Sci. https:\/\/doi.org\/2020;256:117900.","DOI":"10.1016\/j.lfs.2020.117900"},{"issue":"10","key":"10.1016\/j.ctim.2025.103295_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/foods6100092","article-title":"Curcumin: a review of its effects on human health","volume":"6","author":"Hewlings","year":"2017","journal-title":"Foods"},{"issue":"1","key":"10.1016\/j.ctim.2025.103295_bib8","article-title":"A review on antibacterial, antiviral, and antifungal activity of curcumin","volume":"2014","author":"Zorofchian Moghadamtousi","year":"2014","journal-title":"Biomed Res Int"},{"issue":"11","key":"10.1016\/j.ctim.2025.103295_bib9","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/ptr.6738","article-title":"Potential effects of curcumin in the treatment of COVID-19 infection","volume":"34","author":"Zahedipour","year":"2020","journal-title":"Phytother Res"},{"key":"10.1016\/j.ctim.2025.103295_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01021","article-title":"Turmeric and its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications","volume":"11","author":"Sharifi-Rad","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ctim.2025.103295_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2021.104503","article-title":"Promising role of curcumin against viral diseases emphasizing COVID-19 management: A review on the mechanistic insights with reference to host-pathogen interaction and immunomodulation","volume":"82","author":"Dhar","year":"2021","journal-title":"J Funct Foods"},{"issue":"Pt B","key":"10.1016\/j.ctim.2025.103295_bib12","article-title":"Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients","volume":"89","author":"Valizadeh","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.ctim.2025.103295_bib13","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.4067\/S0717-97072022000205537","article-title":"Physicochemical investigation of anti-COVID19 drugs using several medicinal plants","volume":"67","author":"Mollaamin","year":"2022","journal-title":"J Chil Chem Soc"},{"issue":"3","key":"10.1016\/j.ctim.2025.103295_bib14","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.33263\/BRIAC103.575585","article-title":"An overview on coronaviruses family from past to COVID-19: Introduce some inhibitors as antiviruses from Gillan\u2019s plants","volume":"10","author":"Monajjemi","year":"2020","journal-title":"Biointerface Res Appl Chem"},{"issue":"2","key":"10.1016\/j.ctim.2025.103295_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/antib13020038","article-title":"Structural and functional characterization of medicinal plants as selective antibodies towards therapy of COVID-19 symptoms","volume":"13","author":"Mollaamin","year":"2024","journal-title":"Antibodies"},{"issue":"8","key":"10.1016\/j.ctim.2025.103295_bib16","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1002\/fsn3.2226","article-title":"Oral nano-curcumin formulation efficacy in the management of mild to moderate outpatient COVID-19: A randomized triple-blind placebo-controlled clinical trial","volume":"9","author":"Ahmadi","year":"2021","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.ctim.2025.103295_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.669362","article-title":"Oral curcumin with piperine as adjuvant therapy for the treatment of COVID-19: a randomized clinical trial","volume":"12","author":"Pawar","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ctim.2025.103295_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119437","article-title":"Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV-2","volume":"276","author":"Tahmasebi","year":"2021","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.ctim.2025.103295_bib19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/ptr.7724","article-title":"Curcumin for the treatment of COVID-19 patients: A meta-analysis of randomized controlled trials","volume":"37","author":"Shafiee","year":"2023","journal-title":"Phytother Res"},{"issue":"2","key":"10.1016\/j.ctim.2025.103295_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/nu14020256","article-title":"Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials","volume":"14","author":"Vahedian-Azimi","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ctim.2025.103295_bib21","unstructured":"Higgins J.P.T. GSe. Cochrane handbook for systematic reviews of interventions version 5.1.0. March 2011 ed. 2011."},{"key":"10.1016\/j.ctim.2025.103295_bib22","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ctim.2025.103295_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S Group. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.ctim.2025.103295_bib24","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"Cochrane bias methods group; cochrane statistical methods group. the cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"7414","key":"10.1016\/j.ctim.2025.103295_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ctim.2025.103295_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ctim.2025.103295_bib27","series-title":"Introduction to meta-analysis","author":"Borenstein","year":"2021"},{"issue":"7109","key":"10.1016\/j.ctim.2025.103295_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"25","key":"10.1016\/j.ctim.2025.103295_bib29","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1002\/sim.2889","article-title":"Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity","volume":"26","author":"Peters","year":"2007","journal-title":"Stat Med"},{"issue":"7650","key":"10.1016\/j.ctim.2025.103295_bib30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ctim.2025.103295_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175267","article-title":"Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function","volume":"933","author":"Abbaspour-Aghdam","year":"2022","journal-title":"Eur J Pharm"},{"issue":"9","key":"10.1016\/j.ctim.2025.103295_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.humimm.2023.05.003","article-title":"Combining nano-curcumin with catechin improves COVID-19-infected patient's inflammatory conditions","volume":"84","author":"Ahmad Merza Mohammad","year":"2023","journal-title":"Hum Immunol"},{"key":"10.1016\/j.ctim.2025.103295_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5734675","article-title":"Efficacy of nanocurcumin as an add-on treatment for patients hospitalized with COVID-19: a double-blind, randomized clinical trial","volume":"2023","author":"Ahmadi","year":"2023","journal-title":"Int J Clin Pract"},{"issue":"2","key":"10.1016\/j.ctim.2025.103295_bib34","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ptr.7375","article-title":"Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial","volume":"36","author":"Asadirad","year":"2022","journal-title":"Phytother Res"},{"issue":"1","key":"10.1016\/j.ctim.2025.103295_bib35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s13063-022-06375-w","article-title":"The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial","volume":"23","author":"Askari","year":"2022","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.ctim.2025.103295_bib36","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/ptr.7683","article-title":"Phase III randomized clinical trial of BV-4051, an Ayurvedic polyherbal formulation in moderate SARS-CoV-2 infections and its impact on inflammatory biomarkers","volume":"37","author":"Chitre","year":"2023","journal-title":"Phytother Res"},{"issue":"229","key":"10.1016\/j.ctim.2025.103295_bib37","first-page":"70","article-title":"The effect of curcumex supplement (containing turmeric, ginger, and black pepper extract) on clinical manifestations and laboratory findings of patients with COVID-19","volume":"33","author":"Ghasemian","year":"2024","journal-title":"J Mazandaran Univ Med Sci"},{"issue":"1","key":"10.1016\/j.ctim.2025.103295_bib38","first-page":"216","article-title":"The effect of curcumin and virgin coconut oil towards cytokines levels in COVID-19 Patients at Universitas Sebelas Maret Hospital, Surakarta, Indonesia","volume":"14","author":"Hartono","year":"2022","journal-title":"Pharm J"},{"issue":"11","key":"10.1016\/j.ctim.2025.103295_bib39","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1002\/ptr.7294","article-title":"A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients","volume":"35","author":"Hassaniazad","year":"2021","journal-title":"Phytother Res"},{"issue":"11","key":"10.1016\/j.ctim.2025.103295_bib40","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1111\/jcmm.17337","article-title":"Effect of ArtemiC in patients with COVID-19: a phase II prospective study","volume":"26","author":"Hellou","year":"2022","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.ctim.2025.103295_bib41","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/ptr.7374","article-title":"Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: A randomized double-blind placebo-controlled trial","volume":"36","author":"Honarkar Shafie","year":"2022","journal-title":"Phytother Res"},{"key":"10.1016\/j.ctim.2025.103295_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.898062","article-title":"Oral co-supplementation of Curcumin, Quercetin, and Vitamin D3 as an adjuvant therapy for mild to moderate symptoms of COVID-19-results from a pilot open-label, randomized controlled trial","volume":"13","author":"Khan","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ctim.2025.103295_bib43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s41043-024-00584-6","article-title":"Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial","volume":"43","author":"Kishimoto","year":"2024","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.ctim.2025.103295_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8447545","article-title":"A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of a nutritional supplement (ImmuActive(TM)) for COVID-19 patients","volume":"2021","author":"Majeed","year":"2021","journal-title":"Evid Based Complement Altern Med"},{"key":"10.1016\/j.ctim.2025.103295_bib45","article-title":"AYUSH medicine as add-on therapy for mild category COVID-19; an open label randomised, controlled clinical trial","author":"Rao","year":"2020","journal-title":"medRxiv"},{"issue":"8","key":"10.1016\/j.ctim.2025.103295_bib46","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/ptr.7844","article-title":"Promising clinical outcomes of nano-curcumin treatment as an adjunct therapy in hospitalized COVID-19 patients: A randomized, double-blinded, placebo-controlled trial","volume":"37","author":"Sadeghizadeh","year":"2023","journal-title":"Phytother Res"},{"issue":"4","key":"10.1016\/j.ctim.2025.103295_bib47","first-page":"31","article-title":"A prospective, multi center, single blind, randomized controlled study evaluating \"AyurCoro3\" as an adjuvant in the treatment of mild to moderate COVID-19 patients","volume":"6","author":"Sankhe","year":"2021","journal-title":"J Ayurveda Integr Med"},{"key":"10.1016\/j.ctim.2025.103295_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2022.102824","article-title":"A randomized, controlled, blinded, parallel group, clinical trial to study the role of Ayurcov (AyurCoro3), one day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India","volume":"67","author":"Sankhe","year":"2022","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.ctim.2025.103295_bib49","article-title":"The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19\u2014Results from a pragmatic randomized clinical trial","volume":"9","author":"Ujjan","year":"2023","journal-title":"Orig Res Front Nutr"},{"key":"10.1016\/j.ctim.2025.103295_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.863082","article-title":"Pharmaceutical prospects of Curcuminoids for the remedy of COVID-19: truth or myth","volume":"13","author":"Fu","year":"2022","journal-title":"Front Pharm"},{"key":"10.1016\/j.ctim.2025.103295_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111888","article-title":"Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential","volume":"141","author":"Fu","year":"2021","journal-title":"Biomed Pharm"},{"issue":"1","key":"10.1016\/j.ctim.2025.103295_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61662-7","article-title":"Antiviral, anti-inflammatory and antioxidant effects of curcumin and curcuminoids in SH-SY5Y cells infected by SARS-CoV-2","volume":"14","author":"Nicoliche","year":"2024","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ctim.2025.103295_bib53","doi-asserted-by":"crossref","DOI":"10.18103\/mra.v8i10.2248","article-title":"Molecular mechanisms of Curcumin in COVID-19 treatment and prevention: a global health perspective","volume":"8","author":"Roberts","year":"2020","journal-title":"Med Res Arch"},{"key":"10.1016\/j.ctim.2025.103295_bib54","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fcell.2020.00479","article-title":"The inhibitory effect of Curcumin on virus-induced cytokine storm and its potential use in the associated severe pneumonia","volume":"8","author":"Liu","year":"2020","journal-title":"Front Cell Dev Biol"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229925001712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229925001712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:14:40Z","timestamp":1777601680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229925001712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":54,"alternative-id":["S0965229925001712"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2025.103295","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of turmeric for the treatment of COVID-19: An updated systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2025.103295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103295"}}